Oxford NanoLabs becomes Oxford Nanopore Technologies Ltd 21 May 2008
21 May 2008, Oxford, UK. Oxford NanoLabs, the UK-based technology
company, today became Oxford Nanopore Technologies Ltd ("Oxford
Nanopore"). The new name reflects the Company's goal of developing
nanopore technology into market-leading molecular detection and
analysis products for a broad range of applications.
Applications of the Company's nanopore technology include a
revolutionary method of DNA sequencing, portable systems for the
identification of infectious organisms or markers of disease, systems
for the detection of agents of bioterrorism and technology for
integration into drug discovery.
Oxford Nanopore recently raised �10m in a private financing round, to
accelerate the research and development of a new method for DNA
sequencing that is label-free and measures DNA bases at the single
molecule level. These qualities have the potential to deliver a
step-change in the power and cost of DNA analysis.
"Nanopores have been researched for many years by leading academics at
the world's most prestigious institutions," said Dr Gordon Sanghera,
CEO of Oxford Nanopore. "This is groundbreaking science that requires a
multidisciplinary approach to transform it into working products. We
have invested enormous effort into recruiting the very best scientists
and engineers. Together we are focused on delivering molecular analysis
systems that provide real benefits to scientists, and ultimately
improve the health of patients worldwide."
"Oxford Nanopore represents a model partnership between academia and
industry," said Professor Hagan Bayley, founder of Oxford Nanopore and
Professor of Chemical Biology at the University of Oxford. "We will
continue to push the frontiers of nanopore science in an academic
setting, while the Oxford Nanopore team builds on these discoveries in
its innovative technology programme. By putting a company with a superb
development team in support of new fundamental science, nanopore
technology can realise its full potential."
21 May 2008
